ARTICLE

A DEEPER INSIGHT INTO PHARMACOKINETICS OF DRUGS FOLLOWING ONE COMPARTMENT MODEL

03 Pages : 25-33

http://dx.doi.org/10.31703/gpsr.2017(II-I).03      10.31703/gpsr.2017(II-I).03      Published : Dec 2017

A Deeper Insight into Pharmacokinetics of Drugs Following one Compartment Model

    This article discusses the mathematical pharmacokinetic models with reference to one open compartment model in detail. Four types of models, IV, bolus, extravascular 1st and 0 order, have been studied. Mathematical approaches to predict the pharmacokinetic parameters, including elimination half-life, rate constant and drug clearance, have been included. This article focuses on the significance of one open compartment model to study the distribution and elimination of drugs in the body beforehand, to determine whether the drugs under study should proceed to clinical trials or not. Thus, the prediction of the pharmacokinetics of the drug at an earlier stage with the help of this mathematical model saves time and cost during drug and discovery and drug development.

    One Compartment Model, Open Model, Pharmacokinetic Models, Elimination Half-Life, Drug Clearance, Elimination Rate Constant, Pharmacokinetics (PK).
    (1) Syeda Komal Fatima
    Undergraduate Student, Department of Pharmaceutics, Faculty of Pharmacy, Islamia University Bahawalpur, Bahawalpur, Punjab, Pakistan.
    (2) Ayesha Sabir
    Undergraduate Student, Department of Pharmaceutics, Faculty of Pharmacy, Islamia University Bahawalpur, Bahawalpur, Punjab, Pakistan.
    (3) Fahad Pervai
    Associate Professor, Department of Pharmaceutics, Faculty of Pharmacy, Islamia University Bahawalpur, Bahawalpur, Punjab, Pakistan.
  • Ahmed, T. J. B. P. C., & Applications, S. C. (2015). Pharmacokinetics of drugs following IV Bolus, IV infusion, and oral administration. 53-98.
  • Avent, M., Rogers, B., Cheng, A., & Paterson, D. J. I. m. j. (2011). Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity. 41(6), 441-449.
  • Brahmankar, D., & Jaiswal, S. B. (2005). Biopharmaceutics and pharmacokinetics: A treatise: Vallabh prakashan.
  • Carleton, S. A., Kelly, L., Anderson-Sprecher, R., & del Rio, C. M. J. R. C. I. M. S. A. I. J. D. T. T. R. D. o. U. T. T. M. R. i. M. S. (2008). Should we use one-, or multi-compartment models to describe 13C incorporation into animal tissues? , 22(19), 3008-3014.
  • Fernández-Varón, E., Bovaira, M., Espuny, A., Escudero, E., Vancraeynest, D., Cárceles, C. J. J. O. V. P., & therapeutics. (2005). Pharmacokinetic-pharmacodynamic integration of moxifloxacin in rabbits after intravenous, intramuscular and oral administration. 28(4), 343-348.
  • Funatogawa, T., Funatogawa, I., & Yafune, A. J. J. O. B. S. (2007). An estimation method of the half- life for a one-compartment model of a single bolus intravenous injection by a single sampling. 17(5), 827-837.
  • Marsot, A., Boulamery, A., Bruguerolle, B., & Simon, N. J. C. P. (2012). Vancomycin. 51(1), 1-13.
  • Rosenbaum, S. E. J. B. P., Textbook, P. A. I., & Simulations, C. (2016). PHARMACOKINETICS OF AN INTRAVENOUS BOLUS INJECTION IN A ONE-COMPARTMENT MODEL. 159.
  • Savic, R. M., Jonker, D. M., Kerbusch, T., Karlsson, M. O. J. J. O. P., & pharmacodynamics. (2007). Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies. 34(5), 711-726.
  • Shargel, L., Andrew, B., & Wu-Pong, S. (2005). Applied biopharmaceutics & pharmacokinetics.
  • Tang, S., Xiao, Y. J. J. O. P., & Pharmacodynamics. (2007). One-compartment model with Michaelis-Menten elimination kinetics and therapeutic window: an analytical approach. 34(6), 807-827.
  • WU, G. J. P. r. (2000). Sensitivity analysis of pharmacokinetic parameters in one- compartment models. 41(4), 445-453.
  • Yamazaki, S., Skaptason, J., Romero, D., Vekich, S., Jones, H. M., Tan, W., & disposition. (2011). Prediction of oral pharmacokinetics of cMet kinase inhibitors in humans: physiologically based pharmacokinetic model versus traditional one-compartment model. 39(3), 383-393.
  • Zhang, Y., Huo, M., Zhou, J., Xie, S. J. C. M., & biomedicine, P. I. (2010). PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. 99(3), 306-314.

Cite this article

    APA : Fatima, S. K., Sabir, A., & Pervai, F. (2017). A Deeper Insight into Pharmacokinetics of Drugs Following one Compartment Model. Global Pharmaceutical Sciences Review, II(I), 25-33. https://doi.org/10.31703/gpsr.2017(II-I).03
    CHICAGO : Fatima, Syeda Komal, Ayesha Sabir, and Fahad Pervai. 2017. "A Deeper Insight into Pharmacokinetics of Drugs Following one Compartment Model." Global Pharmaceutical Sciences Review, II (I): 25-33 doi: 10.31703/gpsr.2017(II-I).03
    HARVARD : FATIMA, S. K., SABIR, A. & PERVAI, F. 2017. A Deeper Insight into Pharmacokinetics of Drugs Following one Compartment Model. Global Pharmaceutical Sciences Review, II, 25-33.
    MHRA : Fatima, Syeda Komal, Ayesha Sabir, and Fahad Pervai. 2017. "A Deeper Insight into Pharmacokinetics of Drugs Following one Compartment Model." Global Pharmaceutical Sciences Review, II: 25-33
    MLA : Fatima, Syeda Komal, Ayesha Sabir, and Fahad Pervai. "A Deeper Insight into Pharmacokinetics of Drugs Following one Compartment Model." Global Pharmaceutical Sciences Review, II.I (2017): 25-33 Print.
    OXFORD : Fatima, Syeda Komal, Sabir, Ayesha, and Pervai, Fahad (2017), "A Deeper Insight into Pharmacokinetics of Drugs Following one Compartment Model", Global Pharmaceutical Sciences Review, II (I), 25-33
    TURABIAN : Fatima, Syeda Komal, Ayesha Sabir, and Fahad Pervai. "A Deeper Insight into Pharmacokinetics of Drugs Following one Compartment Model." Global Pharmaceutical Sciences Review II, no. I (2017): 25-33. https://doi.org/10.31703/gpsr.2017(II-I).03